BioAffinity Technologies Inc (BIAF) saw an uptrend of 15.18% in the recent trading with $2.58 being its most recent. The current price level -28.73% lower than the highest price of $3.62 marked by the stock while trading over the past 52-weeks, whereas it is 170.21% higher than the lowest price of $0.95 the company dropped to over past 52-weeks. The latest news story on BIAF appeared in (InvestorPlace) under the title “BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023”.
Squeezing the time span to 30 day period shows us the stock is currently trading -28.73% below one month high and is +85.61% above of the lowest during that time. Looking into the simple moving average, BioAffinity Technologies Inc (BIAF)’s stock stands at a SMA-50 of $1.84 while that of 5-day is reading $2.21.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and BIAF’s SMA-200 as of now is $1.64.
BioAffinity Technologies Inc Earnings – What Happened With BIAF
Coming around sales and income figures on BIAF Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
BIAF – BioAffinity Technologies Inc Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 9.39 million. BIAF does have institutional investors; and they hold 1.36% of the stock.
BioAffinity Technologies Inc – Insider Activity and Holdings
As on Jun 29, 2023, Captrust Financial Advisors was the top most holder in BioAffinity Technologies Inc (NASDAQ:BIAF) with an ownership of 43642.0 shares of the company or 0.47% of the stake worth $79864.0. The filing also reveals Two Sigma Investments, LP as the second largest holder in the company with a control over 0.23% of the outstanding shares. Its stake is worth $39970.0 for having 21842.0 shares in hand.
State Street Corporation also came holding a key position in the company during the recent quarter and it now holds 0.19% of the outstanding shares. With this there are now 12 institutions which have possession in BIAF’s shares.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, BioAffinity Technologies Inc has a debt to equity ratio of 0.33.
Technical Analysis of BioAffinity Technologies Inc (NASDAQ:BIAF) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for BioAffinity Technologies Inc (BIAF), we notice that the stock’s 20-day average volume is at 245,400 shares and 100% of short term indicators are suggesting the stock as Buy. Medium term indicators at an average of 100% are spotting the stock at Buy with its 50-day average volume of 228,440 shares. And to end, BIAF’s 100-day average volume is 122,951 shares with 100% of the long-term indicators pointing towards Buy for the stock.
